A First-in-Man Study with 4-Fluoroamphetamine Demonstrates it Produces a Mild Psychedelic State

References

• Bowdle, T. A., A. D. Radant, D. S. Cowley, E. D. Kharasch, R. J. Strassman, and P. P. Roy-Byrne. 1998. Psychedelic effects of ketamine in healthy volunteers: Relationship to steady-state plasma concentrations. Anesthesiology 88 (1):82–88.
   PubMed Web of Science ®Google Scholar
• Bremner, J. D., J. H. Krystal, F. W. Putnam, S. M. Southwick, C. Marmar, D. S. Charney, and C. M. Mazure. 1998. Measurement of dissociative states with the clinician-administered dissociative states scale (CADSS). Journal of Traumatic Stress 11:125–36. doi:10.1023/A:1024465317902.
   PubMed Web of Science ®Google Scholar
• de Sousa Fernandes Perna, E. B., E. L. Theunissen, P. C. Dolder, N. L. Mason, N. R. P. W. Hutten, S. W. Toennes, K. P. C. Kuypers, and J. G. Ramaekers. 2018. Safety profile and neurocognitive function following acute 4-fluoroamphetamine (4-FA) administration in humans. Frontiers in Pharmacology 9 (713). doi: 10.3389/fphar.2018.00713.
   PubMed Web of Science ®Google Scholar
• DeDreu, C., M. Baas, and B. A. Nijstad. 2008. Hedonic tone and activation level in the mood-creativity link: Toward a dual pathway to creativity model. Journal of Personality and Social Psychology 94 (5):739–56. doi:10.1037/0022-3514.94.5.739.
   PubMed Web of Science ®Google Scholar
• Dittrich, A. 1998. The standardized psychometric assessment of altered states of consciousness (ASCs) in humans. Pharmacopsychiatry 31:80–84. doi:10.1055/s-2007-979351.
   PubMed Web of Science ®Google Scholar
• Dolder, P. C., E. B. de Sousa Fernandes Perna, N. L. Mason, N. R. Hutten, S. W. Toennes, E. L. Theunissen, J. G. Ramaekers, and K. P. C. Kuypers. 2018. Independent elevation of peripheral oxytocin concentrations and reduction in cognitive empathy during 4-fluoroamphetamine intoxication. Hum Psychopharmacol 33 (6):e2680. doi:10.1002/hup.2680.
   PubMed Web of Science ®Google Scholar
• EMCDDA. 2015. New psychoactive substances in Europe: An update from the EU early warning system. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.
   Google Scholar
• Farah, M. J., C. Haimm, G. Sankoorikal, M. E. Smith, and A. Chatterjee. 2009. When we enhance cognition with Adderall, do we sacrifice creativity? A preliminary study. Psychopharmacology (Berl) 202 (1–3):541–47. doi:10.1007/s00213-008-1369-3.
   PubMed Web of Science ®Google Scholar
• Fuller, R. W., J. C. Baker, K. W. Perry, and B. B. Molloy. 1975. Comparison of 4-chloro-, 4-bromo- and 4-fluoroamphetamine in rats: Drug levels in brain and effects on brain serotonin metabolism. Neuropharmacology 14 (10):739–46. doi:10.1016/0028-3908(75)90099-4.
   PubMed Web of Science ®Google Scholar
• González, D., J. Riba, J. C. Bouso, G. Gómez-Jarabo, and M. J. Barbanoj. 2006. Pattern of use and subjective effects of Salvia divinorum among recreational users. Drug and Alcohol Dependence 85 (2):157–62. doi:10.1016/j.drugalcdep.2006.04.001.
   PubMed Web of Science ®Google Scholar
• Gvirts, H. Z., N. Mayseless, A. Segev, D. Yael Lewis, K. Feffer, Y. Barnea, Y. Bloch, and S. G. Shamay-Tsoory. 2017. Novelty-seeking trait predicts the effect of methylphenidate on creativity. Journal of Psychopharmacology 31 (5):599–605. doi:10.1177/0269881116667703.
   PubMed Web of Science ®Google Scholar
• Harman, W. W., R. H. McKim, R. E. Mogar, J. Fadiman, and M. J. Stolaroff. 1966. Psychedelic agents in creative problem-solving: A pilot study. Psychological Reports 19:211–27. doi:10.2466/pr0.1966.19.1.211.
   PubMed Web of Science ®Google Scholar
• Hondebrink, L., A. Zwartsen, and R. H. S. Westerink. 2017. Effect fingerprinting of new psychoactive substances (NPS): What can we learn from in vitro data? Pharmacol Ther. doi:10.1016/j.pharmthera.2017.10.022.
   PubMed Web of Science ®Google Scholar
• Hondebrink, L., J. J. Nugteren-van Lonkhuyzen, D. Van Der Gouwe, and T. M. Brunt. 2015. Monitoring new psychoactive substances (NPS) in The Netherlands: Data from the drug market and the poisons information centre. Drug & Alcohol Dependence 147:109–15. doi:10.1016/j.drugalcdep.2014.11.033.
   PubMed Web of Science ®Google Scholar
• Iszáj, F., M. D. Griffiths, and Z. Demetrovics. 2017. Creativity and psychoactive substance use: A systematic review. International Journal of Mental Health and Addiction 15 (5):1135–49. doi:10.1007/s11469-016-9709-8.
   Web of Science ®Google Scholar
• Johanson C. E., M. Kilbey, K. Gatchalian, and M. Tancer. 2006. Discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans trained to discriminate among d-amphetamine, meta-chlorophenylpiperazine and placebo. Drug and Alcohol Dependence 81 (1):27–36. doi:10.1016/j.drugalcdep.2005.05.003.
   PubMed Web of Science ®Google Scholar
• Krystal, J. H., L. P. Karper, J. P. Seibyl, G. K. Freeman. R. Delaney. J. D. Bremner. G. R. Heninger. M. B. Bowers Jr., and D. S. Charney. 1994. Subanesthetic effects of the noncompetitive nmda antagonist, ketamine, in humans: Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Archives of General Psychiatry 51 (3):199–214. doi:10.1001/archpsyc.1994.03950030035004.
   PubMed Web of Science ®Google Scholar
• Kuypers, K. P. C., J. Riba, M. de la Fuente Revenga, S. Barker, E. L. Theunissen, and J. G. Ramaekers. 2016. Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking. Psychopharmacology 233:3395–403. doi:10.1007/s00213-016-4377-8.
   PubMed Web of Science ®Google Scholar
• Liechti, M. E., P. C. Dolder, and Y. Schmid. 2017. Alterations of consciousness and mystical-type experiences after acute LSD in humans. Psychopharmacology 234 (9):1499–510. doi:10.1007/s00213-016-4453-0.
   PubMed Web of Science ®Google Scholar
• Linsen, F., R. P. J. Koning, M. van Laar, R. J. M. Niesink, M. W. Koeter, and T. M. Brunt. 2015. 4-Fluoroamphetamine in the Netherlands: More than a one-night stand. Addiction 110 (7):1138–43. doi:10.1111/add.12932.
   PubMed Web of Science ®Google Scholar
• MacLean, K. A., M. W. Johnson, C. J. Reissig, T. E. Prisinzano, and R. R. Griffiths. 2013. Dose-related effects of salvinorin A in humans: Dissociative, hallucinogenic, and memory effects. Psychopharmacology 226 (2):381–92. doi:10.1007/s00213-012-2912-9.
   PubMed Web of Science ®Google Scholar
• Monshouwer, K., P. van der Pol, Y. C. Drost, and M. W. van Laar. 2016. Het grote uitgaansonderzoek 2016: Uigaanspatronen, middelengebruik en preventieve maatregelen onder uitgaande jongeren en jongvolwassenen. Utrecht: Trimbos Institute.
   Google Scholar
• Nagai, F., R. Nonaka, and K. Satoh Hisashi Kamimura. 2007. The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain. European Journal of Pharmacology 559 (2):132–37. doi:10.1016/j.ejphar.2006.11.075.
   PubMed Web of Science ®Google Scholar
• Nugteren-van Lonkhuyzen, J. J., A. J. H. P. van Riel, T. M. Brunt, and L. Hondebrink. 2015. Pharmacokinetics, pharmacodynamics and toxicology of new psychoactive substances (NPS): 2C-B, 4-fluoroamphetamine and benzofurans. Drug and Alcohol Dependence No 157:18–27. doi:10.1016/j.drugalcdep.2015.10.011.
   PubMed Web of Science ®Google Scholar
• Pérez-Fabello, M. J., and A. Campos. 2011. Dissociative experiences and creativity in fine arts students. Creativity Research Journal 23 (1):38–41. doi:10.1080/10400419.2011.545721.
   Web of Science ®Google Scholar
• Puxty, D. J., J. G. Ramaekers, R. de la Torre, M. Farré, N. Pizarro, M. Pujadas, and K. P. C. Kuypers. 2017. MDMA-induced dissociative state not mediated by the 5-HT2A receptor. Frontiers in Pharmacology 8 (455). doi: 10.3389/fphar.2017.00455.
   PubMed Web of Science ®Google Scholar
• Riba, J., S. Romero, E. Grasa, E. Mena, I. Carrió, and M. Barbanoj. 2006. Increased frontal and paralimbic activation following ayahuasca, the pan-amazonian inebriant. Psychopharmacology 186 (1):93–98. doi:10.1007/s00213-006-0358-7.
   PubMed Web of Science ®Google Scholar
• Riba, J., A. Rodrı́guez-Fornells, R. J. Strassman, and M. J. Barbanoj. 2001. Psychometric assessment of the hallucinogen rating scale. Drug and Alcohol Dependence 62 (3):215–23. doi:10.1016/S0376-8716(00)00175-7.
   PubMed Web of Science ®Google Scholar
• Richardson, J. T. E. 2011. Eta squared and partial eta squared as measures of effect size in educational research. Educational Research Review 6 (2):135–47. doi:10.1016/j.edurev.2010.12.001.
   Web of Science ®Google Scholar
• Rickli, A., M. C. Hoener, and M. E. Liechti. 2015. Monoamine transporter and receptor interaction profiles of novel psychoactive substances: Para-halogenated amphetamines and pyrovalerone cathinones. European Neuropsychopharmacology 25 (3):365–76. doi:10.1016/j.euroneuro.2014.12.012.
   PubMed Web of Science ®Google Scholar
• Strassman, R. J., C. R. Qualls, E. H. Uhlenhuth, and R. Kellner. 1994. Dose-response study of n,n-dimethyltryptamine in humans: Ii. subjective effects and preliminary results of a new rating scale. Archives of General Psychiatry 51 (2):98–108. doi:10.1001/archpsyc.1994.03950020022002.
   PubMed Web of Science ®Google Scholar
• Studerus, E., A. Gamma, and F. X. Vollenweider. 2010. Psychometric evaluation of the altered states of consciousness rating scale (OAV). Public Library of Science ONE 5 (8):e12412.
   Google Scholar
• Tancer, M., and C.-E. Johanson. 2003. Reinforcing, subjective, and physiological effects of MDMA in humans: A comparison with d-amphetamine and mCPP. Drug and Alcohol Dependence 72 (1):33–44.
   PubMed Web of Science ®Google Scholar
• van Heugten–van der Kloet, D., J. Cosgrave, H. Merckelbach, R. Haines, S. Golodetz, and S. J. Lynn. 2015. Imagining the impossible before breakfast: The relation between creativity, dissociation, and sleep. Frontiers in Psychology 6:324. doi:10.3389/fpsyg.2015.00324.
   PubMed Web of Science ®Google Scholar
• van Heugten–Van der Kloet, D., T. Giesbrecht, J. van Wel, W. M. Bosker, K. P. C. Kuypers, E. L. Theunissen, D. B. Spronk, R. Jan Verkes, H. Merckelbach, and J. G. Ramaekers. 2015. MDMA, cannabis, and cocaine produce acute dissociative symptoms. Psychiatry Res 228 (3):907–12. doi:10.1016/j.psychres.2015.04.028.
   PubMed Web of Science ®Google Scholar
• van Wel, J. H. P., D. B. Spronk, K. P. C. Kuypers, E. L. Theunissen, S. W. Toennes, R. J. Verkes, and J. G. Ramaekers. 2015. Psychedelic symptoms of cannabis and cocaine use as a function of trait impulsivity. Journal of Psychopharmacology 29:324–34. doi:10.1177/0269881114563633.
   PubMed Web of Science ®Google Scholar
• Vollenweider, F. X., R. P. Maguire, K. L. Leenders, K. Mathys, and J. Angst. 1998. Effects of high amphetamine dose on mood and cerebral glucose metabolism in normal volunteers using positron emission tomography (PET). Psychiatry Research: Neuroimaging 83 (3):149–62. doi:10.1016/S0925-4927(98)00033-X.
   Web of Science ®Google Scholar